S. Li
6 Papers
S. Li is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 1, co-authored 6 publications.
Chat about Author
Papers
High energy-power zinc-ion hybrid supercapacitors achieved by 3D channels enriched biomass-derived N/O co-doped 2D arcuate carbon nanosheets
TL;DR: In this article , the intrinsic feature of well-developed metabolic channels is effectively converted into a novel N/O co-doped 2D arcuate carbon nanosheets cathode for high energy-power ZIHSCs.
20
High temperature performance and interface evolution of a NiCoCrAlY coating with Pt modification and Re-based diffusion barrier
M.M. Xu,S. Li,Zhuoxu Dong,H. Liu,Zixian Bao,S.L. Zhu,F. Wang +6 more
TL;DR: In this article , the atomic immigration and electron location function (ELF) at the Ni-Re interface were simulated by density function theory (DFT) calculations, showing that the incorporation of Co made the energy difference more negative, which confirmed that Co promoted the diffusion of Re in the NiCoCrAlY coating.
8
Effect of low concentration of melatonin on the quality of stored red blood cells in vitro
S. Li,Li Zhang,Huaiyu Yuan,L. Yang,F. Song,H Liu,Chun-Hua Wei,Hai-Qin Ding,Qiang Ma +8 more
TL;DR: In this article , the effect of low melatonin concentration on the stored red blood cells (RBCs) in vitro was investigated, and it was shown that low hypnotic drug concentration of MT is speculated to have protective effects on the quality of stored RBCs through antioxidative mechanism.
1
A Redundancy-free IFC Storage Platform For Multi-model Scenarios based on Block Hash
TL;DR: The main idea of the approach is to divide model files into appropriate blocks and calculate the hash values of these blocks to reuse the them in different models to efficiently make the database redundancy-free.
[Tumor cell lysate with low content of HMGB1 enhances immune response of dendritic cells against lung cancer in mice].
TL;DR: In this paper , the effect of tumor cell lysate (TCL) with low high-mobility group B1 (HMGB1) content for enhancing immune responses of dendritic cells (DCs) against lung cancer was assessed.